prednisone has been researched along with Erythroderma, Sezary in 20 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL)." | 9.09 | Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. ( Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C, 1999) |
| "This Phase II study was undertaken to assess the efficacy and toxicity of chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone (EPOCH regimen) in patients with advanced, refractory cutaneous T-cell lymphoma (CTCL)." | 5.09 | Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. ( Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C, 1999) |
| "We describe a 55-year-old woman suffering from Sezary syndrome, had undergone chemotherapy consisting of cycles of cyclophosphamide and prednisone." | 3.79 | Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation. ( Aouem, K; Belhadjali, H; Laatiri, A; Mokni, S; Moussa, A; Youssef, M; Zili, J, 2013) |
| "Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists." | 3.77 | Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome. ( Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F, 2011) |
| "Leonine facies is rare and corresponds to the morphologic manifestation of diffuse dermal infiltration of the face." | 1.37 | Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab. ( Alves, R; Lima, M; Lobo, I; Oliveira, A; Selores, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novelli, S | 1 |
| Martín, A | 1 |
| Sánchez, JJ | 1 |
| Espeso, M | 1 |
| Mozos, A | 1 |
| Briones, J | 1 |
| Youssef, M | 1 |
| Mokni, S | 1 |
| Belhadjali, H | 1 |
| Aouem, K | 1 |
| Moussa, A | 1 |
| Laatiri, A | 1 |
| Zili, J | 1 |
| Pileri, A | 1 |
| Pellegrini, C | 1 |
| Agostinelli, C | 1 |
| Grandi, V | 1 |
| Patrizi, A | 1 |
| Zinzani, PL | 1 |
| Pimpinelli, N | 1 |
| Kahata, K | 1 |
| Hashino, S | 1 |
| Takahata, M | 1 |
| Fujisawa, F | 1 |
| Kondo, T | 1 |
| Kobayashi, S | 1 |
| Fujita, Y | 1 |
| Shimizu, H | 1 |
| Imamura, M | 1 |
| Asaka, M | 1 |
| Curry, JL | 1 |
| Prieto, VG | 1 |
| Jones, DM | 1 |
| Vega, F | 1 |
| Duvic, M | 2 |
| Diwan, AH | 1 |
| Jurkovicova, J | 1 |
| Xicoy, B | 1 |
| Bielsa, I | 1 |
| Arellano, A | 1 |
| Oliveira, A | 1 |
| Lobo, I | 1 |
| Alves, R | 1 |
| Lima, M | 1 |
| Selores, M | 1 |
| Winkelmann, RK | 3 |
| Diaz-Perez, JL | 1 |
| Buechner, SA | 1 |
| Weinerman, BH | 1 |
| Lu, LC | 1 |
| Pineda, AA | 2 |
| Zachariae, H | 1 |
| Bjerring, P | 1 |
| Brodthagen, U | 1 |
| Søgaard, H | 1 |
| Zhang, Q | 1 |
| Nowak, I | 1 |
| Vonderheid, EC | 1 |
| Rook, AH | 1 |
| Kadin, ME | 1 |
| Nowell, PC | 1 |
| Shaw, LM | 1 |
| Wasik, MA | 1 |
| Fierro, MT | 1 |
| Doveil, GC | 1 |
| Quaglino, P | 1 |
| Savoia, P | 1 |
| Verrone, A | 1 |
| Bernengo, MG | 2 |
| Akpek, G | 1 |
| Koh, HK | 1 |
| Bogen, S | 1 |
| O'Hara, C | 1 |
| Foss, FM | 1 |
| McMullan, DM | 1 |
| Radovaneević, B | 1 |
| Jackow, CM | 1 |
| Frazier, OH | 1 |
| Delsignore, R | 1 |
| Quaini, F | 1 |
| Rizzoli, V | 1 |
| Baroni, MC | 1 |
| Zavaroni, G | 1 |
| Butturini, U | 1 |
| Hamminga, L | 1 |
| Hartgrink-Groeneveld, CA | 1 |
| van Vloten, WA | 1 |
| McEvoy, MT | 1 |
| Zelickson, BD | 1 |
| Dearden, CE | 1 |
| Matutes, E | 1 |
| Hoffbrand, AV | 1 |
| Ganeshaguru, K | 1 |
| Brozovic, M | 1 |
| Williams, HJ | 1 |
| Traub, N | 1 |
| Mills, M | 1 |
| Linch, DC | 1 |
| Catovsky, D | 1 |
| Meregalli, M | 1 |
| Jemma, C | 1 |
| Lisa, F | 1 |
1 review available for prednisone and Erythroderma, Sezary
| Article | Year |
|---|---|
Cutaneous T-cell lymphoma in a cardiac transplant recipient.
Topics: Aged; Azathioprine; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosu | 2001 |
1 trial available for prednisone and Erythroderma, Sezary
| Article | Year |
|---|---|
Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemothera | 1999 |
18 other studies available for prednisone and Erythroderma, Sezary
| Article | Year |
|---|---|
Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cyclopho | 2020 |
Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Hyper | 2013 |
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermat | 2017 |
Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide | 2008 |
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Im | 2011 |
[Sustained molecular remission in an adult patient with Sézary syndrome after peripheral allogeneic stem-cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Fema | 2011 |
Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biop | 2011 |
The treatment of Sézary syndrome.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy | 1984 |
Sézary syndrome-an unusual case.
Topics: Administration, Topical; Chlorambucil; Female; Humans; Leukocyte Count; Mechlorethamine; Prednisone; | 1981 |
Leukapheresis in the treatment of Sézary syndrome.
Topics: Adult; Aged; Blood Cell Count; Chlorambucil; Drug Therapy, Combination; Female; Humans; Leukapheresi | 1981 |
Photopheresis in the red man or pre-Sézary syndrome.
Topics: Acitretin; Aged; Dermatitis, Exfoliative; Follow-Up Studies; Humans; Male; Mechlorethamine; Middle A | 1995 |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Topics: Cell Membrane; Cyclosporine; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Janus Kinase 3; | 1996 |
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Al | 1997 |
[Sézary syndrome with terminal evolution in acute myeloblastic leukemia].
Topics: Aged; Antineoplastic Agents; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Pred | 1979 |
Sézary's syndrome: a clinical evaluation of eight patients.
Topics: Aged; Bone Marrow; Chlorambucil; Female; Humans; Leukocyte Count; Lymph Nodes; Lymphocytes; Male; Mi | 1979 |
Intermittent leukapheresis: an adjunct to low-dose chemotherapy for Sézary syndrome.
Topics: Chlorambucil; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Leukapheresis; M | 1989 |
Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 1987 |
Functional properties in Sézary cells with an unusual phenotype.
Topics: Aged; Antibodies, Monoclonal; Chlorambucil; Dermatitis, Exfoliative; Drug Therapy, Combination; Huma | 1985 |